An Open-label, Phase IV study evaluating lidose-isotretinoin administered without food in patients with severe recalcitrant nodular acne: Low relapse rates observed over the 104-week post-treatment period

James Q. Del Rosso, Linda Stein Gold, Jeanett Segal, Andrea L. Zaenglein

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'An Open-label, Phase IV study evaluating lidose-isotretinoin administered without food in patients with severe recalcitrant nodular acne: Low relapse rates observed over the 104-week post-treatment period'. Together they form a unique fingerprint.

Medicine & Life Sciences